#As a compound cisplatin was first described by M. Peyrone in 1845 (known as Peyrone s salt). The structure was elucidated by Alfred Werner in 1893. It was rediscovered in the 1960s by Barnett Rosenberg and van Campet al, who discovered that electrolysis products from a platinum electrode inhibited mitosis in Escherichia coli (E. coli) bacteria. The bacteria grow to 300 times their normal length but cell division fails..
#(S1 (S (SBAR (IN As) (S (NP (DT a) (NN compound) (NN cisplatin)) (VP (AUX was) (ADVP (RB first)) (VP (VBN described) (PP (IN by) (NP (NNP M.) (NNP Peyrone))) (PP (IN in) (NP (NP (CD 1845)) (PRN (-LRB- -LRB-) (VP (VBN known) (PP (IN as) (NP (NNP Peyrone) (NNP s) (NN salt)))) (-RRB- -RRB-)) (. .))))))) (NP (DT The) (NN structure)) (VP (AUX was) (VP (VBN elucidated) (PP (IN by) (NP (NNP Alfred) (NNP Werner))) (PP (IN in) (S (VP (VBG 1893.) (SBAR (S (NP (PRP It)) (VP (AUX was) (VP (VBN rediscovered) (PP (IN in) (NP (DT the) (NNS 1960s))) (PP (IN by) (NP (NP (NNP Barnett) (NNP Rosenberg)) (CC and) (NP (NP (NN van) (NNP Campet) (NNP al)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD discovered) (SBAR (S (IN that) (NP (NP (NN electrolysis) (NNS products)) (PP (IN from) (NP (DT a) (NN platinum) (NN electrode)))) (VP (VBD inhibited) (SBAR (S (NP (NP (NNS mitosis)) (PP (IN in) (NP (NP (NNP Escherichia) (NNS coli)) (PRN (-LRB- -LRB-) (NP (NNP E.) (NNS coli)) (-RRB- -RRB-))))) (VP (VBD bacteria.) (SBAR (S (NP (DT The) (NNS bacteria)) (VP (VBP grow) (PP (TO to) (NP (CD 300) (NNS times))) (SBAR (S (NP (PRP$ their) (JJ normal) (NN length) (CC but) (NN cell) (NN division)) (VP (VBZ fails))))))))))) (. .)))))))))))))))))) (. .)))
#Rule:Nouns
r1compoundNN
r1cisplatinNN
r1M. PeyronePersonAnnotation
r1Peyrone sPersonAnnotation
r1saltNN
r1structureNN
r1Alfred WernerPersonAnnotation
r11960sNNS
r1Barnett RosenbergPersonAnnotation
r1van CampetPersonAnnotation
r1alNNP
r1electrolysisNN
r1productsNNS
r1platinumNN
r1electrodeNN
r1mitosisNNS
r1EscherichiaLocationAnnotation
r1coliNNS
r1E. coliLocationAnnotation
r1bacteriaNNS
r1timesNNS
r1lengthNN
r1cellNN
r1divisionNN

#Rule:Verbs
r2describedVBN
r2knownVBN
r2elucidatedVBN
r21893VBG
r2rediscoveredVBN
r2discoveredVBD
r2inhibitedVBD
r2bacteriaVBD
r2growVBP
r2failsVBZ

#Rule:Adjs
r4normalJJ

#Rule:Adj-Noun
r5300CDtimesNNS
r5normalJJdivisionNN

#Rule:PRP-Noun
r6theirPRP$divisionNN

#Rule:N-HeadNoun
r8compoundNNcisplatinNN
r8Peyrone sPersonAnnotationsaltNN
r8van CampetPersonAnnotationalNNP
r8electrolysisNNproductsNNS
r8platinumNNelectrodeNN
r8EscherichiaLocationAnnotationcoliNNS
r8cellNNdivisionNN

#Rule:HeadNoun-V
r11productsNNSinhibitedVBD
r11mitosisNNSbacteriaVBD
r11bacteriaNNSgrowVBP
r11divisionNNfailsVBZ

#Rule:V-By-Agent
r13M. PeyronePersonAnnotationdescribedVBN
r13Alfred WernerPersonAnnotationelucidatedVBN
r13Barnett RosenbergPersonAnnotationrediscoveredVBN
r13alNNPrediscoveredVBN

#Rule:HeadNoun-(who/that)-V
r14alNNPdiscoveredVBD

#Rule:V-HeadNoun(passive)
r23elucidatedVBNstructureNN
r23describedVBNcisplatinNN
r23rediscoveredVBNitPRP

#Rule:PPinNP
r26productsNNSfromINelectrodeNN
r26mitosisNNSinINcoliNNS

#Rule:PPinVP
r30growVBPtoTOtimesNNS

#Rule:PPinVP
r32describedVBNinIN1845CD
r32knownVBNasINsaltNN
r32rediscoveredVBNinIN1960sNNS

#Rule:V-ADV
r46wasAUXfirstRB
r46describedVBNfirstRB

#In the 1970s, a series of experiments were conducted at Michigan State University to test the effects the cis-diamminedichloroplatinum(II), along with other platinum coordination complexes, on sarcomas artificially implanted in rats. This study found that cis-diamminedichloroplatinum(II) was the most effective out of this group, which started the medicinal career of cisplatin..
#(S1 (S (PP (IN In) (NP (DT the) (CD 1970s))) (, ,) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS experiments)))) (VP (AUX were) (VP (VBN conducted) (PP (IN at) (NP (NNP Michigan) (NNP State) (NNP University))) (S (VP (TO to) (VP (VB test) (NP (DT the) (NNS effects)) (NP (NP (DT the) (NN cis-diamminedichloroplatinum)) (PRN (-LRB- -LRB-) (NP (NNP II)) (-RRB- -RRB-)) (, ,) (PP (IN along) (PP (IN with) (NP (JJ other) (NN platinum) (NN coordination) (NNS complexes)))) (, ,) (PP (IN on) (NP (NP (NNS sarcomas)) (VP (ADVP (RB artificially)) (VBN implanted) (PP (IN in) (NP (NP (NN rats.)) (SBAR (S (NP (DT This) (NN study)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN cis-diamminedichloroplatinum)) (PRN (-LRB- -LRB-) (NP (NNP II)) (-RRB- -RRB-))) (VP (AUX was) (NP (NP (DT the) (RBS most) (JJ effective)) (PP (IN out) (PP (IN of) (NP (NP (DT this) (NN group)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD started) (NP (NP (DT the) (JJ medicinal) (NN career)) (PP (IN of) (NP (NN cisplatin)))))))))))))))))))))) (. .))))))) (. .)))
#Rule:Nouns
r1seriesNN
r1experimentsNNS
r1Michigan State UniversityOrganizationAnnotation
r1effectsNNS
r1cis-diamminedichloroplatinumPersonAnnotation
r1IINNP
r1platinumNN
r1coordinationNN
r1complexesNNS
r1sarcomasNNS
r1ratsNN
r1studyNN
r1cis-diamminedichloroplatinum(IIOrganizationAnnotation
r1groupNN
r1careerNN
r1cisplatinNN

#Rule:Verbs
r2conductedVBN
r2testVB
r2implantedVBN
r2foundVBD
r2startedVBD

#Rule:Adjs
r4otherJJ
r4effectiveJJ
r4medicinalJJ

#Rule:Adj-Noun
r5otherJJcomplexesNNS
r5medicinalJJcareerNN

#Rule:N-HeadNoun
r8coordinationNNcomplexesNNS
r8platinumNNcomplexesNNS

#Rule:HeadNoun-V
r11studyNNfoundVBD
r11cis-diamminedichloroplatinum(IIOrganizationAnnotationwasAUX

#Rule:HeadNoun-(who/that)-V
r14groupNNstartedVBD

#Rule:NP(NP(z) SBAR(S(NP(x)VP(y))))
r19foundVBDratsNN

#Rule:V-HeadNoun
r21testVBeffectsNNS
r21testVBcis-diamminedichloroplatinumPersonAnnotation
r21wasAUXeffectiveJJ
r21startedVBDcareerNN

#Rule:V-HeadNoun(passive)
r23conductedVBNseriesNN

#Rule:V-HeadNoun(passive)
r24implantedVBNsarcomasNNS

#Rule:PPinNP
r26seriesNNofINexperimentsNNS
r26cis-diamminedichloroplatinumPersonAnnotationonLocationAnnotationsarcomasNNS
r26careerNNofINcisplatinNN

#Rule:PPComboInNP
r27cis-diamminedichloroplatinumPersonAnnotationalongINcomplexesNNS
r27effectiveJJoutINgroupNN

#Rule:PPinVP
r32conductedVBNatINMichigan State UniversityOrganizationAnnotation
r32implantedVBNinINratsNN

#Rule:PPinS
r36wereAUXinIN1970sCD

#Rule:V-IN-V
r43foundVBDthatINwasAUX

#Rule:V-V
r44conductedVBNtestVB

#Rule:V-ADV
r46implantedVBNartificiallyRB

#Rule:IS-RULE
r47effectiveJJcis-diamminedichloroplatinum(IIOrganizationAnnotation

#Approved for clinical use by the United States Food and Drug Administration (FDA) in 1978, it revolutionized the treatment of certain cancers. Detailed studies on its molecular mechanism of action, using a variety of spectrocopic methods including X-ray, NMR and other physico-chemical methods, revealed its ability to form irreversible crosslinks with bases in DNA.
#(S1 (S (S (VP (VBN Approved) (PP (IN for) (NP (JJ clinical) (NN use))) (PP (IN by) (NP (DT the) (NNP United) (NNP States) (NNP Food) (CC and) (NNP Drug) (NNP Administration) (PRN (-LRB- -LRB-) (NP (NNP FDA)) (-RRB- -RRB-)))) (PP (IN in) (NP (CD 1978))))) (, ,) (NP (PRP it)) (VP (VBD revolutionized) (SBAR (S (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ certain) (JJ cancers.) (JJ Detailed) (NNS studies)) (PP (IN on) (NP (NP (PRP$ its) (JJ molecular) (NN mechanism)) (PP (IN of) (NP (NN action))))))) (, ,) (VP (VBG using) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ spectrocopic) (NNS methods)) (PP (VBG including) (NP (UCP (NN X-ray) (, ,) (NN NMR) (CC and) (JJ other)) (JJ physico-chemical) (NNS methods))))))) (, ,)) (VP (VBD revealed) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB form) (NP (JJ irreversible) (NNS crosslinks)) (PP (IN with) (NP (NP (NNS bases)) (PP (IN in) (NP (NNP DNA))))))))))))) (. .)))
#Rule:Nouns
r1useNN
r1United States Food and Drug AdministrationOrganizationAnnotation
r1FDAOrganizationAnnotation
r1treatmentNN
r1studiesNNS
r1mechanismNN
r1actionNN
r1varietyNN
r1methodsNNS
r1X-rayNN
r1NMROrganizationAnnotation
r1methodsNNS
r1abilityNN
r1crosslinksNNS
r1basesNNS
r1DNALocationAnnotation

#Rule:Verbs
r2approvedVBN
r2revolutionizedVBD
r2usingVBG
r2includingVBG
r2revealedVBD
r2formVB

#Rule:Adjs
r4clinicalJJ
r4certainJJ
r4cancersJJ
r4DetailedJJ
r4molecularJJ
r4spectrocopicJJ
r4otherJJ
r4physico-chemicalJJ
r4irreversibleJJ

#Rule:Adj-Noun
r5clinicalJJuseNN
r5certainJJstudiesNNS
r5cancersJJstudiesNNS
r5DetailedJJstudiesNNS
r5molecularJJmechanismNN
r5spectrocopicJJmethodsNNS
r5physico-chemicalJJmethodsNNS
r5irreversibleJJcrosslinksNNS

#Rule:PRP-Noun
r6itsPRP$mechanismNN
r6itsPRP$abilityNN

#Rule:HeadNoun-V
r11itPRPrevolutionizedVBD
r11treatmentNNrevealedVBD
r11treatmentNNusingVBG

#Rule:V-By-Agent
r13United States Food and Drug AdministrationOrganizationAnnotationapprovedVBN

#Rule:V-HeadNoun
r21usingVBGvarietyNN
r21revealedVBDabilityNN
r21formVBcrosslinksNNS

#Rule:PPinNP
r26treatmentNNofINstudiesNNS
r26studiesNNSonINmechanismNN
r26mechanismNNofINactionNN
r26varietyNNofINmethodsNNS
r26basesNNSinINDNALocationAnnotation

#Rule:PPinVP
r30formVBwithINbasesNNS

#Rule:PPinVP
r32approvedVBNforINuseNN
r32approvedVBNinIN1978CD

@lemmas-left	using	compound	test	treatment	Barnett Rosenberg	conducted	bases	mechanism	crosslinks	its	approved	fail	E. coli	1893.	chemical	describe	inhibit	Escherichia	mitosis	structure	1893	form	cell	career	effects	molecular	rats.	revolutionized	include	cancers.	start	implanted	x-ray	Alfred Werner	series	cis-diamminedichloroplatinum(II	complex	fails	coordination	implant	use	effective	division	elucidated	times	experiments	1960s	Michigan State University	detailed	length	clinical	products	ability	cis-diamminedichloroplatinum	physico-chemical	product	including	United States Food and Drug Administration	bacteria	base	DNA	sarcomas	medicinal	X-ray	method	rediscovered	discovered	described	rediscover	methods	reveal	complexes	normal	revealed	study	inhibited	studies	elucidate	conduct	were	experiment	revolutionize	action	coli	bacteria.	irreversible	be	II	approve	300	discover	electrode	M. Peyrone	platinum	FDA	sarcoma	known	salt	van Campet	other	Peyrone s	was	spectrocopic	cisplatin	NMR	rats	Detailed	it	ii	know	variety	cancers	al	grow	electrolysis	certain	started	their	group	found	
@lemmas-right	methods	rediscover	using	reveal	complexes	test	bases	revealed	mechanism	crosslinks	study	inhibited	studies	elucidate	approved	fail	describe	experiment	action	revolutionize	1978	coli	inhibit	bacteria.	be	approve	structure	discover	career	effects	rats.	revolutionized	electrode	start	sarcoma	salt	cis-diamminedichloroplatinum(II	series	complex	fails	use	effective	was	division	elucidated	times	experiments	1960s	Michigan State University	1970s	cisplatin	products	rats	ability	1845	it	cis-diamminedichloroplatinum	variety	product	al	grow	bacteria	base	DNA	sarcomas	method	artificially	started	rediscovered	group	discovered	first	described	found	
@lemmas-center	to	that	of	with	for	at	on	as	along	from	in	out	